Home  

Enter a class name or drug name above to search the database.

Passively Acquired Immunity [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
60492-0173 CNJ-016 Vaccinia Immune Globulin Intravenous (Human) Emergent BioSolutions Canada Inc. INJECTION 2005-05-02
68403-1100 BabyBIG human botulinum neurotoxin a/b immune globulin CALIFORNIA DEPARTMENT OF PUBLIC HEALTH INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 2003-10-23
69800-0250 ASCENIV HUMAN IMMUNOGLOBULIN G ADMA Biologics, Inc. LIQUID 2019-04-01
69800-4203 Nabi-HB Hepatitis B Immune Globulin (Human) ADMA Biologics, Inc. LIQUID 2001-10-23
69800-6502 BIVIGAM Immune Globulin Intravenous (Human) 10% ADMA Biologics, Inc. INJECTION, SOLUTION 2013-01-21
69800-6503 BIVIGAM Immune Globulin Intravenous (Human) 10% ADMA Biologics, Inc. INJECTION, SOLUTION 2013-01-21
70257-051 HepaGam B Hepatitis B Immune Globulin Intravenous (Human) Saol Therapeutics Inc. INJECTION 2019-03-01
70257-052 HepaGam B Hepatitis B Immune Globulin Intravenous (Human) Saol Therapeutics Inc. INJECTION 2019-03-01
76179-010 QIVIGY kthm human immunoglobulin g Kedrion S.p.A. INJECTION, SOLUTION 2025-09-26

 Physiological Effect (PE) Classification 

Loading full table content...